Motif Bio Share Price - MTFB

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Motif Bio PLC MTFB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0346 23.63% 0.181 0.19 0.15 0.15 0.1464 11:29:46
Bid Price Ask Price Spread Spread % News
0.18 0.181 0.001 0.55% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume
1,089 1,584,793  0.1678269  265,971 735,844
Last Trade Time Type Quantity Stock Price Currency
11:29:46 300  0.181 USD

Motif Bio Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio
 2.74M 17.12M  -13.99M -1.40 - 17.12M
Dividends Per Share Dividend Yield
-  - 0.00% - -

more financials information »

News Motif Bio

Loading Messages....

Latest MTFB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

MTFB Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Motif Bio PLC is a UK-based biopharmaceutical company. Its business is to develop antibiotics for the treatment of infections caused by multi-drug resistant bacteria. The company's key product is the Iclaprim, which addresses bacterial infections, such as acute bacterial skin and skin structure infections and hospital-acquired bacterial pneumonia. Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. Motif Bio generates revenue from the sale of its pharmaceutical products mainly in the United Kingdom.


Your Recent History
NASDAQ
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.